Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,490
0.00 (0.00%)
At close: Sep 5, 2025

Whan In Pharm Revenue

Whan In Pharm had revenue of 64.14B KRW in the quarter ending June 30, 2025, with 0.81% growth. This brings the company's revenue in the last twelve months to 258.70B, up 6.70% year-over-year. In the year 2024, Whan In Pharm had annual revenue of 259.60B with 12.68% growth.

Revenue (ttm)
258.70B
Revenue Growth
+6.70%
P/S Ratio
0.62
Revenue / Employee
427.61M
Employees
605
Market Cap
160.15B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024259.60B29.20B12.68%
Dec 31, 2023230.39B31.46B15.81%
Dec 31, 2022198.93B21.16B11.90%
Dec 31, 2021177.78B6.07B3.54%
Dec 31, 2020171.71B12.53B7.87%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics5,031.69B
Celltrion3,748.95B
ALTEOGEN158.06B
Yuhan2,165.44B
SK Biopharmaceuticals620.28B
Peptron5.18B
PharmaResearch449.81B
ABL Bio94.93B
Revenue Rankings